NEXENTIS TECHNOLOGIES INC. Gain (Loss) on Investments
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Gain (Loss) on Investments of -$469.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. gain (loss) on investments for the quarter ending 2026-06-30 was -$469.00K.
- NEXENTIS TECHNOLOGIES INC. gain (loss) on investments for the quarter ending 2026-03-31 was $492.00K, a 377.67% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. gain (loss) on investments for the quarter ending 2025-12-31 was $844.00K.
- NEXENTIS TECHNOLOGIES INC. gain (loss) on investments for the quarter ending 2025-09-30 was -$149.00K.
- NEXENTIS TECHNOLOGIES INC. gain (loss) on investments for fiscal 2025 was $351.00K.
- NEXENTIS TECHNOLOGIES INC. gain (loss) on investments for fiscal 2024 was -$1.21M.
- NEXENTIS TECHNOLOGIES INC. gain (loss) on investments for fiscal 2023 was -$714.00K.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 3 month as first filed | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 6 month as first filed | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 9 month as first filed | Gain (Loss) on Investments 12 month | Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$469.00K 10-Q · filed 2026-08-13 | $24.00K 10-Q · filed 2026-08-13 | $867.00K derived: sum of 3 quarters · filed 2026-08-13 | $718.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $492.00K 10-Q · filed 2026-05-14 | $1.34M derived: sum of 2 quarters · filed 2026-05-14 | $1.19M derived: sum of 3 quarters · filed 2026-05-14 | $661.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $844.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $695.00K derived: sum of 2 quarters · filed 2026-03-31 | $169.00K derived: sum of 3 quarters · filed 2026-08-13 | $351.00K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$149.00K 10-Q · filed 2025-11-13 | -$675.00K derived: sum of 2 quarters · filed 2026-08-13 | -$493.00K 10-Q · filed 2025-11-13 | -$927.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$526.00K 10-Q · filed 2026-08-13 | -$520.00K 10-Q · filed 2025-08-14 | -$344.00K 10-Q · filed 2026-08-13 | -$349.00K 10-Q · filed 2025-08-14 | -$778.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.75M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $103.00K 10-Q · filed 2026-05-14 | $175.00K 10-Q · filed 2025-05-15 | -$252.00K derived: sum of 2 quarters · filed 2026-05-14 | -$1.22M derived: sum of 3 quarters · filed 2026-05-14 | -$1.19M derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -$355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.33M derived: sum of 2 quarters · filed 2026-03-31 | -$1.30M derived: sum of 3 quarters · filed 2026-03-31 | -$1.21M 10-K · filed 2026-03-31 | -$1.30M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$971.00K 10-Q · filed 2025-11-13 | -$970.50K 10-Q · filed 2024-11-14 | -$941.00K derived: sum of 2 quarters · filed 2025-11-13 | -$857.00K 10-Q · filed 2025-11-13 | -$856.84K 10-Q · filed 2024-11-14 | -$1.48M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $30.00K 10-Q · filed 2025-08-14 | $29.73K 10-Q · filed 2024-08-14 | $114.00K 10-Q · filed 2025-08-14 | $113.67K 10-Q · filed 2024-08-14 | -$512.42K derived: sum of 3 quarters · filed 2025-08-14 | -$702.11K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $84.00K 10-Q · filed 2025-05-15 | $83.94K 10-Q · filed 2024-05-15 | -$542.42K derived: sum of 2 quarters · filed 2025-05-15 | -$732.11K derived: sum of 3 quarters · filed 2025-05-15 | -$630.00K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$626.42K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$816.11K derived: sum of 2 quarters · filed 2025-03-31 | -$714.00K derived: sum of 3 quarters · filed 2025-03-31 | -$714.00K 10-K · filed 2025-03-31 | -$713.59K 10-K · filed 2024-04-01 | |||
| 2023-09-30 | -$189.68K 10-Q · filed 2024-11-14 | -$87.58K derived: sum of 2 quarters · filed 2024-11-14 | -$87.58K 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | $102.11K 10-Q · filed 2024-08-14 | $102.11K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |